A patient with known G6PD deficiency develops anemia after e…
A patient with known G6PD deficiency develops anemia after exposure to a new medication. The nurse practitioner identifies this as: a dose-related toxic effect of the drug leading to anemia. an idiosyncratic reaction related to genetic variability in metabolism. a hypersensitivity reaction mediated by IgE. a predictable pharmacodynamic interaction.
Read DetailsA patient taking a CYP2C9 substrate for anticoagulation begi…
A patient taking a CYP2C9 substrate for anticoagulation begins a new medication that induces the CYP2C9 pathway. The nurse practitioner would expect to see: unchanged serum concentrations due to renal clearance. decreased anticoagulant effect due to enhanced metabolism. elevated drug levels and bleeding due to inhibition. increased toxicity from protein displacement.
Read DetailsPeople with Type A behavior patterns are at high risk not on…
People with Type A behavior patterns are at high risk not only due to stress, but also due to their hard-driving and competitive lifestyles that often include high-risk behaviors such as smoking, drinking alcohol to excess, and failure to exercise.
Read Details